Capgemini, a multinational information technology services and consulting company headquartered in France, has published a report on the future of quantum computing in life science. With quantum computing, new therapies can be introduced faster and more efficiently in the coming decade. However, while the technology offers companies a great opportunity, it also raises important questions about when and where to invest, and how to position those investments for long-term success. The Future of Quantum in Life Sciences Report offers life sciences executives a primer on the rapidly advancing technology and outlines four steps they can follow to build a scalable quantum computing program.
With quantum computing, new therapies can be introduced faster and more efficiently in the coming decade.However, while the technology offers companies a significant opportunity, it also raises critical questions about when and where to invest, and how to position those investments for long-term success. The report suggests four key actions life sciences companies can take to prepare themselves for the quantum future:
Action 1: To adjust R&D
Action 2: To develop a quantum roadmap
Action 3: Build quantum skills and expertise
Action 4: Develop a partner ecosystem
Full text here (PDF)